OASIS: Are CNS cell-specific survival mechanisms just a mirage?

被引:0
|
作者
Dunn, IF
Friedlander, RM
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:N8 / N8
页数:1
相关论文
共 50 条
  • [21] The Dual RhoGEF Kalirin Reduces Atherosclerosis Through Endothelial Cell-Specific Mechanisms
    Black-Maier, Eric W.
    Wu, Jiao-Hui
    Fanaroff, Alexander C.
    Akella, Padmastuti
    Zhang, Lisheng
    Brian, Leigh
    Stiber, Jonathan A.
    Peppel, Karsten
    Eipper, Betty A.
    Mains, Richard
    Freedman, Neil J.
    CIRCULATION, 2013, 128 (22)
  • [22] Cell-specific therapy on target
    Daniel T. W. Clarke
    Nigel A. J. McMillan
    Nature Nanotechnology, 2014, 9 : 568 - 569
  • [23] CELL-SPECIFIC LEUKOCYTE ESTERASES
    SWEETMAN, FR
    ANSLEY, HR
    ORNSTEIN, L
    FEDERATION PROCEEDINGS, 1972, 31 (02) : A630 - &
  • [24] Cell-specific epigenetic modulation
    McHugh, Jessica
    NATURE REVIEWS RHEUMATOLOGY, 2018, 14 (10) : 562 - 562
  • [25] Cell-Specific Nucleosome Fingerprints
    Cerveny, Kara L.
    CELL, 2011, 146 (03) : 341 - 341
  • [27] Cell-specific epigenetic modulation
    Jessica McHugh
    Nature Reviews Rheumatology, 2018, 14 : 562 - 562
  • [28] Cell-specific ablation in plants
    Thorsness, MK
    Nasrallah, JB
    METHODS IN CELL BIOLOGY, VOL 50, 1995, 50 : 439 - 448
  • [29] Cell-specific gene delivery to the adult and in utero CNS using pseudotyped non-integrating lentivirus
    Rahim, Ahad
    Ward, Natalie
    Waddington, Simon
    Elston, Kaitlan
    Cooper, Jonathan
    Philpott, Nicola
    Anderson, Patrick
    Thrasher, Adrian
    Raivich, Gennadij
    HUMAN GENE THERAPY, 2007, 18 (10) : 1027 - 1027
  • [30] Improving cell-specific recombination using AAV vectors in the murine CNS by capsid and expression cassette optimization
    Kawabata, Hayato
    Konno, Ayumu
    Matsuzaki, Yasunori
    Sato, Yumika
    Kawachi, Mika
    Aoki, Ryo
    Tsutsumi, Saki
    Togai, Shota
    Kobayashi, Ryosuke
    Horii, Takuro
    Hatada, Izuho
    Hirai, Hirokazu
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2024, 32 (01)